FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1989548699> ?p ?o ?g. }

• W1989548699 endingPage "e41347" @default.
• W1989548699 startingPage "e41347" @default.
• W1989548699 abstract "The employment of anti-epidermal growth factor receptor (EGFR) antibodies represents a backbone of the therapeutic options for the treatment of metastatic colorectal cancer (mCRC). However, this therapy is poorly effective or ineffective in unselected patients. Mutations in KRAS, BRAF and PIK3CA genes have recently emerged as the best predictive factors of low/absent response to EGFR-targeted therapy. Due to the need for efficacious treatment options for mCRC patients bearing these mutations, in this short report we examined the antitumoral activity of the protease inhibitor gabexate mesilate, alone and in combination with the anti-EGFR monoclonal antibody cetuximab, in a panel of human CRC cell lines harbouring a different expression pattern of wild-type/mutated KRAS, BRAF and PIK3CA genes. Results obtained showed that gabexate mesilate significantly inhibited the growth, invasive potential and tumour-induced angiogenesis in all the CRC cells employed in this study (including those ones harbouring dual KRAS/PIK3CA or BRAF/PIK3CA mutation), while cetuximab affected these parameters only in CRC cells with KRAS, BRAF and PIK3CA wild-type. Notably, the antitumoral efficacy of gabexate mesilate and cetuximab in combination was found to be not superior than that observed with gabexate mesilate as single agent. Overall, these preliminary findings suggest that gabexate mesilate could represent a promising therapeutic option for mCRC patients, particularly for those harbouring KRAS, BRAF and PIK3CA mutations, either as mono-therapy or in addition to standard chemotherapy regimens. Further studies to better elucidate gabexate mesilate mechanism of action in CRC cells are therefore warranted." @default.
• W1989548699 created "2016-06-24" @default.
• W1989548699 creator A5008455426 @default.
• W1989548699 creator A5030289522 @default.
• W1989548699 creator A5049091400 @default.
• W1989548699 creator A5055160804 @default.
• W1989548699 creator A5066637157 @default.
• W1989548699 creator A5067159913 @default.
• W1989548699 creator A5067741259 @default.
• W1989548699 creator A5068055005 @default.
• W1989548699 date "2012-07-24" @default.
• W1989548699 modified "2023-09-24" @default.
• W1989548699 title "Antitumoral Efficacy of the Protease Inhibitor Gabexate Mesilate in Colon Cancer Cells Harbouring KRAS, BRAF and PIK3CA Mutations" @default.
• W1989548699 cites W1983197520 @default.
• W1989548699 cites W2007226924 @default.
• W1989548699 cites W2035351580 @default.
• W1989548699 cites W2038624343 @default.
• W1989548699 cites W2049843003 @default.
• W1989548699 cites W2050548777 @default.
• W1989548699 cites W2073840675 @default.
• W1989548699 cites W2074473619 @default.
• W1989548699 cites W2084911268 @default.
• W1989548699 cites W2100490225 @default.
• W1989548699 cites W2106789440 @default.
• W1989548699 cites W2108468456 @default.
• W1989548699 cites W2108637466 @default.
• W1989548699 cites W2125756326 @default.
• W1989548699 cites W2131371081 @default.
• W1989548699 cites W2134519717 @default.
• W1989548699 cites W2143899076 @default.
• W1989548699 cites W2155311724 @default.
• W1989548699 cites W2161593277 @default.
• W1989548699 cites W2166335627 @default.
• W1989548699 cites W2167539263 @default.
• W1989548699 cites W2169460990 @default.
• W1989548699 cites W4236891330 @default.
• W1989548699 doi "https://doi.org/10.1371/journal.pone.0041347" @default.
• W1989548699 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3404056" @default.
• W1989548699 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22911782" @default.
• W1989548699 hasPublicationYear "2012" @default.
• W1989548699 type Work @default.
• W1989548699 sameAs 1989548699 @default.
• W1989548699 citedByCount "14" @default.
• W1989548699 countsByYear W19895486992012 @default.
• W1989548699 countsByYear W19895486992013 @default.
• W1989548699 countsByYear W19895486992014 @default.
• W1989548699 countsByYear W19895486992016 @default.
• W1989548699 countsByYear W19895486992017 @default.
• W1989548699 countsByYear W19895486992018 @default.
• W1989548699 countsByYear W19895486992019 @default.
• W1989548699 countsByYear W19895486992020 @default.
• W1989548699 crossrefType "journal-article" @default.
• W1989548699 hasAuthorship W1989548699A5008455426 @default.
• W1989548699 hasAuthorship W1989548699A5030289522 @default.
• W1989548699 hasAuthorship W1989548699A5049091400 @default.
• W1989548699 hasAuthorship W1989548699A5055160804 @default.
• W1989548699 hasAuthorship W1989548699A5066637157 @default.
• W1989548699 hasAuthorship W1989548699A5067159913 @default.
• W1989548699 hasAuthorship W1989548699A5067741259 @default.
• W1989548699 hasAuthorship W1989548699A5068055005 @default.
• W1989548699 hasBestOaLocation W19895486991 @default.
• W1989548699 hasConcept C121608353 @default.
• W1989548699 hasConcept C126322002 @default.
• W1989548699 hasConcept C143998085 @default.
• W1989548699 hasConcept C2776694085 @default.
• W1989548699 hasConcept C2778332735 @default.
• W1989548699 hasConcept C2779438470 @default.
• W1989548699 hasConcept C2779998722 @default.
• W1989548699 hasConcept C2781187634 @default.
• W1989548699 hasConcept C502942594 @default.
• W1989548699 hasConcept C526805850 @default.
• W1989548699 hasConcept C71924100 @default.
• W1989548699 hasConcept C98274493 @default.
• W1989548699 hasConceptScore W1989548699C121608353 @default.
• W1989548699 hasConceptScore W1989548699C126322002 @default.
• W1989548699 hasConceptScore W1989548699C143998085 @default.
• W1989548699 hasConceptScore W1989548699C2776694085 @default.
• W1989548699 hasConceptScore W1989548699C2778332735 @default.
• W1989548699 hasConceptScore W1989548699C2779438470 @default.
• W1989548699 hasConceptScore W1989548699C2779998722 @default.
• W1989548699 hasConceptScore W1989548699C2781187634 @default.
• W1989548699 hasConceptScore W1989548699C502942594 @default.
• W1989548699 hasConceptScore W1989548699C526805850 @default.
• W1989548699 hasConceptScore W1989548699C71924100 @default.
• W1989548699 hasConceptScore W1989548699C98274493 @default.
• W1989548699 hasIssue "7" @default.
• W1989548699 hasLocation W19895486991 @default.
• W1989548699 hasLocation W19895486992 @default.
• W1989548699 hasLocation W19895486993 @default.
• W1989548699 hasLocation W19895486994 @default.
• W1989548699 hasLocation W19895486995 @default.
• W1989548699 hasLocation W19895486996 @default.
• W1989548699 hasOpenAccess W1989548699 @default.
• W1989548699 hasPrimaryLocation W19895486991 @default.
• W1989548699 hasRelatedWork W1992065343 @default.
• W1989548699 hasRelatedWork W2066082532 @default.
• W1989548699 hasRelatedWork W2123328339 @default.
• W1989548699 hasRelatedWork W2144453024 @default.

• next